Lost password ?
<< Back to Equity Research
Gulf Pharmaceutical
JULPHAR, WAITING FOR A SAFETY MARGIN
Apr 15 - Gulf Pharmaceuticals (Add, UAE) is growing at strong steps in the GCC region confirming, once again, the huge sector potential in the region. Although, it was hit by the geopolitical issues in Iraq ...
Executive summary
Conflict of Interest
Pages 40
Language English
Publish on April 15, 2024
€ 500
VAT Exl.
You might be also interested by these reports :
Apr 29 PM
SIPHAT
The mess continues
Apr 29 PM
SIPHAT
Declining revenue
Apr 25 AM
UNIMED
Double-digit growth in Q1
Apr 15 PM
Idea Kicker
JULPHAR, WAITING FOR A SAFETY MARGIN
FIND A REPORT
CONCEPT
Each company is researched in depth using a structured robust and transparent process.

AlphaMena provides analyses based upon exhaustive and homogeneous information which allows to compare stocks geographically, sector-wise, and by thematic.

The analyses include actuarial as well as off balance-sheet data.
BloombergStarmineFactsetReutersCapital IQ